February 28, 2020 / 11:37 AM / a month ago

BRIEF-EMA Says CHMP Recommended Granting Marketing Authorisation For Fetcroja

Feb 28 (Reuters) - European Medicines Agency:

* CHMP RECOMMENDED GRANTING MARKETING AUTHORISATION FOR FETCROJA

* CHMP ADOPTED NEGATIVE OPINION FOR EXTENSION OF INDICATION FOR EMGALITY TO ADD PREVENTION OF ATTACKS IN ADULTS WITH EPISODIC CLUSTER HEADACHE

* APPLICATION FOR USE OF OPDIVO AND YERVOY IN TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER NOT TREATED PREVIOUSLY WAS WITHDRAWN

* CHMP RECOMMEND ADDITION OF NEW PHARMACEUTICAL FORM FOR ENTYVIO: 108 MG SOLUTION FOR INJECTION TO BE GIVEN SUBCUTANEOUSLY Source text for Eikon: [ID: bit.ly/2ToszJ9] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below